Skip to content

Intravenous Dexamethasone to Prolong Caudal Block Analgesia in Children Undergoing Hip Surgery

Effect of Intravenous Dexamethasone on the Duration of Caudal Block Analgesia in Children Undergoing Surgery for Developmental Dysplasia of the Hip: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07896304
Acronym
DEXA-CAUDAL
Enrollment
54
Registered
2026-10-26
Start date
2019-09-01
Completion date
2020-12-01
Last updated
2026-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Developmental Dysplasia of the Hip

Keywords

caudal block, dexamethasone, postoperative analgesia, pediatric anesthesia, regional anesthesia, bupivacaine, CHEOPS

Brief summary

The goal of this clinical trial is to learn whether a single intravenous dose of dexamethasone prolongs postoperative analgesia after a caudal block in children aged 6 months to 9 years undergoing surgery for developmental dysplasia of the hip. The main question it aims to answer is: does intravenous dexamethasone (0.5 mg/kg) lengthen the time to first rescue analgesic compared with placebo? Researchers compared dexamethasone with normal saline (placebo). All children received general anesthesia and a caudal block with bupivacaine 0.25%, and pain was assessed with the CHEOPS score during the first 24 postoperative hours.

Detailed description

This prospective, randomized, double-blind, placebo-controlled trial was conducted in the Department of Anesthesiology and Intensive Care of the Children's Hospital Bechir Hamza of Tunis between September 2019 and December 2020, after approval by the local ethics committee and written informed consent from a parent. Children aged 6 months to 9 years, weighing 20 kg or less, ASA physical status I or II, scheduled for unilateral or bilateral surgery for developmental dysplasia of the hip, were eligible. Anesthesia was induced by inhalation of sevoflurane 8% in a 50% nitrous oxide/oxygen mixture, followed by propofol 2 mg/kg and fentanyl 3 µg/kg after peripheral venous access. The trachea was intubated, ventilation was controlled (tidal volume 7 ml/kg, end-tidal CO2 target 35 mmHg) and anesthesia was maintained with sevoflurane at 1 MAC. At induction, children were randomized with the Random Allocation software to receive either dexamethasone 0.5 mg/kg (0.5 ml/kg of a 1 mg/ml solution, maximum 10 mg) intravenously (Group D) or the same volume of normal saline (Group P). The physician administering the study solution, the child and the parents were blinded to group allocation. A single-shot caudal block was then performed in the lateral position with a 22 G, 30 mm short-bevel caudal needle, injecting 1 ml/kg of plain bupivacaine 0.25% after negative aspiration. Surgical incision took place at least 10 minutes after the block. Block failure was defined as an increase of more than 20% in heart rate and/or blood pressure from baseline within 20 minutes of incision; these children received fentanyl 2 µg/kg and were excluded. No analgesic was given routinely after surgery. Pain was assessed with the CHEOPS score at awakening, 30 minutes and 1, 2, 3, 4, 8, 12 and 24 hours after surgery. A CHEOPS score of 7 or more triggered intravenous paracetamol 15 mg/kg; if the score remained above 7 after 30 minutes, nalbuphine 0.2 mg/kg was infused over 20 minutes. The primary outcome was the time to first analgesic request, from caudal block to first analgesic administration. Secondary outcomes were the number and type of analgesics given, the incidence of postoperative nausea and vomiting, and perioperative anesthetic or surgical adverse events. Sample size: based on a previous trial in children undergoing orchidopexy (time to first analgesic 8.33 ± 0.98 h with dexamethasone versus 6.00 ± 1.15 h with placebo), 26 children per group were required (two-sided alpha 5%, beta 5%). Data were analyzed with IBM SPSS 23 using Pearson's chi-square test, Student's t-test or the Mann-Whitney test as appropriate, and Kaplan-Meier survival analysis for the primary outcome. A p-value below 0.05 was considered significant.

Interventions

DRUGDexamethasone

Single intravenous dose of 0.5 mg/kg (maximum 10 mg), diluted to 1 mg/ml, given at induction of general anesthesia.

DRUGNormal Saline

Single intravenous dose of 0.5 ml/kg of 0.9% sodium chloride at induction of general anesthesia, identical in volume to the active solution.

Single-shot caudal epidural block with plain bupivacaine 0.25%, 1 ml/kg, performed after induction with a 22 G short-bevel caudal needle, at least 10 minutes before incision.

Sponsors

National Institute of Neurology, Tunisia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
6 Months to 9 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 6 months to 9 years * Body weight of 20 kg or less * ASA physical status I or II * Scheduled for surgery for unilateral or bilateral developmental dysplasia of the hip * Eligible for caudal analgesia * Written informed consent from a parent

Exclusion criteria

* Parental refusal * Contraindication to inhalational induction with sevoflurane * Contraindication to caudal block * Coagulation disorder or anticoagulant treatment * Allergy to local anesthetics * Intellectual disability * Corticosteroid treatment in the days before surgery

Design outcomes

Primary

MeasureTime frameDescription
Time to first analgesic requestFrom caudal block to 24 hours after surgeryTime in minutes from completion of the caudal block to the first administration of a rescue analgesic, given when the CHEOPS score reached 7 or more (CHEOPS range 4-13, higher scores indicate more pain).

Secondary

MeasureTime frameDescription
Number of rescue analgesic dosesUp to 24 hours after surgeryTotal number of paracetamol and nalbuphine doses administered per child.
Type of rescue analgesicUp to 24 hours after surgeryProportion of children receiving paracetamol alone, or paracetamol and nalbuphine.
Postoperative pain scoreAt awakening, 30 minutes, 1, 2, 3, 4, 8, 12 and 24 hours after surgeryCHEOPS score (range 4-13, higher scores indicate more pain).
Incidence of postoperative nausea and vomitingUp to 24 hours after surgeryProportion of children with at least one episode of nausea or vomiting.
Perioperative adverse eventsFrom induction to 24 hours after surgeryNumber of children with anesthetic or surgical adverse events.

Countries

Tunisia

Contacts

PRINCIPAL_INVESTIGATORRabeb Hammami

Children's Hospital of Tunis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 27, 2026